180 related articles for article (PubMed ID: 35027542)
21. Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.
Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
Neoplasia; 2019 May; 21(5):459-468. PubMed ID: 30959276
[TBL] [Abstract][Full Text] [Related]
22. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
[TBL] [Abstract][Full Text] [Related]
23. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
24. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
25. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
26. MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma.
Jin C; Han-Hua D; Qiu-Meng L; Deng N; Peng-Chen D; Jie M; Lei X; Xue-Wu Z; Hui-Fang L; Yan C; Xiao-Ping C; Bi-Xiang Z
Oncogene; 2023 Jan; 42(3):169-183. PubMed ID: 36385375
[TBL] [Abstract][Full Text] [Related]
27. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.
Li KS; Zhu XD; Liu HD; Zhang SZ; Li XL; Xiao N; Liu XF; Xu B; Lei M; Zhang YY; Shi WK; Cao MQ; Xu YF; Tang ZY; Sun HC
Cell Death Dis; 2020 May; 11(5):335. PubMed ID: 32382041
[TBL] [Abstract][Full Text] [Related]
28. Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.
Hu J; Muller KA; Furnari FB; Cavenee WK; VandenBerg SR; Gonias SL
Oncogene; 2015 Jul; 34(31):4078-88. PubMed ID: 25347738
[TBL] [Abstract][Full Text] [Related]
29. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
[TBL] [Abstract][Full Text] [Related]
30. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p.
Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F
Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942
[TBL] [Abstract][Full Text] [Related]
31. Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.
Pu J; Wu X; Wu Y; Shao Z; Luo C; Tang Q; Wang J; Wei H; Lu Y
Aging (Albany NY); 2021 Mar; 13(8):12207-12223. PubMed ID: 33952719
[TBL] [Abstract][Full Text] [Related]
32. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
Guo Y; He X; Zhang M; Qu Y; Gu C; Ren M; Wang H; Ning W; Li J; Yu C; Zhang H
J Neurooncol; 2020 Apr; 147(2):327-337. PubMed ID: 32170633
[TBL] [Abstract][Full Text] [Related]
34. MiR-615 inhibits cell proliferation, migration and invasion by targeting EGFR in human glioblastoma.
Ji Y; Sun Q; Zhang J; Hu H
Biochem Biophys Res Commun; 2018 May; 499(3):719-726. PubMed ID: 29605294
[TBL] [Abstract][Full Text] [Related]
35. TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.
Sang Y; Li Y; Song L; Alvarez AA; Zhang W; Lv D; Tang J; Liu F; Chang Z; Hatakeyama S; Hu B; Cheng SY; Feng H
Cancer Res; 2018 Apr; 78(7):1792-1804. PubMed ID: 29386185
[TBL] [Abstract][Full Text] [Related]
36. INHBB promotes tumor aggressiveness and stemness of glioblastoma via activating EGFR signaling.
Yang X; Jia Q; Zou Z; Liu X; Li X; Chen H; Ma H; Chen L
Pathol Res Pract; 2023 May; 245():154460. PubMed ID: 37116368
[TBL] [Abstract][Full Text] [Related]
37. Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells.
Ayuso-Sacido A; Moliterno JA; Kratovac S; Kapoor GS; O'Rourke DM; Holland EC; García-Verdugo JM; Roy NS; Boockvar JA
J Neurooncol; 2010 May; 97(3):323-37. PubMed ID: 19855928
[TBL] [Abstract][Full Text] [Related]
38. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H
Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621
[TBL] [Abstract][Full Text] [Related]
39. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
40. Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.
Wang K; Park JO; Zhang M
J Gene Med; 2013 Jan; 15(1):42-50. PubMed ID: 23319157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]